Eluxadoline is currently under investigation for treatment of diarrhea and pain associated with IBS-D in patients uncontrolled by diet or OTC medications. Recently, two phase III clinical trials examined the safety and efficacy of eluxadoline in both female and male patients with IBS-D. 8 IBS-D involves abnormally increased GI motility and secretions, leading to stool urgency and abdominal pain. 2 Altering the function of these opioid receptors may improve symptoms and help regulate colon function. 8 This article will discuss the use of eluxadoline in